Financials
Financial year 2025
Pharma Steenokkerzeel from Steenokkerzeel, company number BE0889759719, closed financial year 2025 with a result of € 332,125 after tax. For that financial year Pharma Steenokkerzeel recorded a gross margin of € 543,652 and equity of € 1 million. Compared with financial year 2024, the result moved from € 201,826 to € 332,125. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 1 million
▲ 49% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 332,125
▲ 65% vs 2024
Profit after tax over the fiscal year.
€ 397,064
▲ 228% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 606,045.
People and assets in 2025
€ 8,574
▲ 49% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 658
▼ 81% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 89,874
▲ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,639
▲ € 15,734 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 651,588 | € 589,940 | € 371,764 | € 543,652 | ▲ 46% |
| Profit after taxes | € 300,934 | € 372,026 | € 201,826 | € 332,125 | ▲ 65% |
| Equity | € 1,005,432 | € 772,764 | € 674,590 | € 1,006,715 | ▲ 49% |
| Total debts | € 132,947 | € 285,996 | € 352,192 | € 109,542 | ▼ 69% |
| Cash | € 102,426 | € 119,848 | € 121,181 | € 397,064 | ▲ 228% |
| Retained profit | € 604,761 | € 372,093 | € 273,920 | € 606,045 | ▲ 121% |
| Dividend | € 25,000 | € 604,694 | € 300,000 | € 0 | ▼ 100% |
| Balance sheet total | € 1,138,379 | € 1,058,760 | € 1,026,783 | € 1,116,257 | ▲ 9% |
Key figures of Pharma Steenokkerzeel, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharma Steenokkerzeel?
What happened at Pharma Steenokkerzeel in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 332,125 (▲ 65% vs 2024). Source: NBB ↗
- Cornette An BV became a director. NBB
- De Ridder Thomas BV became a director. NBB
- New establishment in Steenokkerzeel. KBO
- Start of the company according to the CBE. KBO
In short
From € 300,934 profit in 2022 to € 332,125 profit in 2025.
Paid € 356,071 in corporate taxes since 2022.
Best year ever: 2023, with € 372,026 profit.
Paid out € 929,694 in dividends to the owners in total.
A new publication or filing at Pharma Steenokkerzeel? We notify you, reason included.
Follow Pharma SteenokkerzeelDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Cornette An, De Ridder Thomas comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Pharma SteenokkerzeelBehind Pharma Steenokkerzeel are De Ridder Thomas BV and Cornette An BV. The shares are held by Cornette An (50%) and De Ridder Thomas (50%).
Directors
According to the 2025 annual accounts
Bestuurder · represented by Thomas De Ridder
since 2019
Bestuurder · represented by An Cornette
since 2020
Shareholders
50%
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Haachtsesteenweg 21
1820 Steenokkerzeel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0889.759.719
- VAT number
- BE 0889.759.719
- Registered office
- Haachtsesteenweg 21, 1820 Steenokkerzeel
- Names & denominations
- Pharma Steenokkerzeel
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2007
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen